标题
Management of Idiopathic Pulmonary Fibrosis
作者
关键词
Pharmacotherapy, Idiopathic pulmonary fibrosis, Palliative care
出版物
CLINICS IN CHEST MEDICINE
Volume 42, Issue 2, Pages 275-285
出版商
Elsevier BV
发表日期
2021-05-21
DOI
10.1016/j.ccm.2021.03.004
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Ambulatory oxygen in fibrotic ILD: a pilot, randomised, triple-blinded, sham-controlled trial
- (2020) Yet H. Khor et al. CHEST
- Supplemental oxygen improves exercise capacity in IPF patients with exertional desaturation
- (2020) Shinichi Arizono et al. RESPIROLOGY
- Pirfenidone plus inhaled N-acetylcysteine for idiopathic pulmonary fibrosis: a randomised trial
- (2020) Susumu Sakamoto et al. EUROPEAN RESPIRATORY JOURNAL
- Therapeutic effects of nintedanib are not influenced by emphysema in the INPULSIS trials
- (2019) Vincent Cottin et al. EUROPEAN RESPIRATORY JOURNAL
- Randomised, double-blind, placebo-controlled pilot trial of omeprazole in idiopathic pulmonary fibrosis
- (2019) Prosenjit Dutta et al. THORAX
- Frailty and geriatric conditions in older patients with idiopathic pulmonary fibrosis
- (2019) Jamie S. Sheth et al. RESPIRATORY MEDICINE
- A randomised, placebo-controlled study of omipalisib (PI3K/mTOR) in idiopathic pulmonary fibrosis
- (2019) Pauline T. Lukey et al. EUROPEAN RESPIRATORY JOURNAL
- Lung Microbiota Contribute to Pulmonary Inflammation and Disease Progression in Pulmonary Fibrosis
- (2019) David N O'Dwyer et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Comprehensive Supportive Care for Patients with Fibrosing Interstitial Lung Disease
- (2019) Marlies S Wijsenbeek et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Oxygen in Patients with Fibrotic Interstitial Lung Disease: An International Delphi Survey
- (2019) Rachel K. Lim et al. EUROPEAN RESPIRATORY JOURNAL
- Long-term treatment with recombinant human pentraxin 2 protein in patients with idiopathic pulmonary fibrosis: an open-label extension study
- (2019) Ganesh Raghu et al. Lancet Respiratory Medicine
- Preoperative Evaluation of Patients With Interstitial Lung Disease
- (2019) Nina M. Patel et al. CHEST
- Effect of pirfenidone on breathlessness in patients with idiopathic pulmonary fibrosis
- (2019) Marilyn K. Glassberg et al. EUROPEAN RESPIRATORY JOURNAL
- CV safety of nintedanib in subgroups by CV risk at baseline in the TOMORROW and INPULSIS trials
- (2019) Imre Noth et al. EUROPEAN RESPIRATORY JOURNAL
- Cough: New Pharmacology
- (2019) Jaclyn A. Smith et al. Journal of Allergy and Clinical Immunology-In Practice
- Pamrevlumab, an anti-connective tissue growth factor therapy, for idiopathic pulmonary fibrosis (PRAISE): a phase 2, randomised, double-blind, placebo-controlled trial
- (2019) Luca Richeldi et al. Lancet Respiratory Medicine
- Comorbidities in idiopathic pulmonary fibrosis: an underestimated issue
- (2019) Antonella Caminati et al. European Respiratory Review
- Nintedanib with Add-on Pirfenidone in Idiopathic Pulmonary Fibrosis. Results of the INJOURNEY Trial
- (2018) Carlo Vancheri et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Treatment of Interstitial Lung Disease associated cough: CHEST guideline and expert panel report
- (2018) Surinder S. Birring et al. CHEST
- Safety of Nintedanib Added to Pirfenidone Treatment for Idiopathic Pulmonary Fibrosis
- (2018) Kevin R. Flaherty et al. EUROPEAN RESPIRATORY JOURNAL
- Effect of Recombinant Human Pentraxin 2 vs Placebo on Change in Forced Vital Capacity in Patients With Idiopathic Pulmonary Fibrosis
- (2018) Ganesh Raghu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Beyond Idiopathic Pulmonary Fibrosis Diagnosis: Multidisciplinary Care With an Early Integrated Palliative Approach Is Associated With a Decrease in Acute Care Utilization and Hospital Deaths
- (2018) Meena Kalluri et al. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
- Idiopathic Pulmonary Fibrosis
- (2018) David J. Lederer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Delay and inequalities in the treatment of idiopathic pulmonary fibrosis: the case of two Nordic countries
- (2018) Ida Pesonen et al. MULTIDISCIPLINARY RESPIRATORY MEDICINE
- Safety, tolerability, pharmacokinetics, and pharmacodynamics of GLPG1690, a novel autotaxin inhibitor, to treat idiopathic pulmonary fibrosis (FLORA): a phase 2a randomised placebo-controlled trial
- (2018) Toby M Maher et al. Lancet Respiratory Medicine
- Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial of BMS-986020, a Lysophosphatidic Acid Receptor Antagonist for the Treatment of Idiopathic Pulmonary Fibrosis
- (2018) Scott M. Palmer et al. CHEST
- Identifying Barriers to Idiopathic Pulmonary Fibrosis Treatment: A Survey of Patient and Physician Views
- (2018) Toby M. Maher et al. RESPIRATION
- Laparoscopic anti-reflux surgery for the treatment of idiopathic pulmonary fibrosis (WRAP-IPF): a multicentre, randomised, controlled phase 2 trial
- (2018) Ganesh Raghu et al. Lancet Respiratory Medicine
- Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomised controlled trial
- (2018) Dina Visca et al. Lancet Respiratory Medicine
- Phase 2 clinical trial of PBI-4050 in patients with idiopathic pulmonary fibrosis
- (2018) Nasreen Khalil et al. EUROPEAN RESPIRATORY JOURNAL
- Safety of benzodiazepines and opioids in interstitial lung disease: A national prospective study
- (2018) Sabrina Bajwah et al. EUROPEAN RESPIRATORY JOURNAL
- Targeting interleukin-13 in idiopathic pulmonary fibrosis: from promising path to dead end
- (2018) Marlies S. Wijsenbeek et al. EUROPEAN RESPIRATORY JOURNAL
- Nintedanib in Idiopathic Pulmonary Fibrosis: Practical Management Recommendations for Potential Adverse Events
- (2018) Elisabeth Bendstrup et al. RESPIRATION
- Baseline characteristics of idiopathic pulmonary fibrosis: analysis from the Australian Idiopathic Pulmonary Fibrosis Registry
- (2017) Helen E. Jo et al. EUROPEAN RESPIRATORY JOURNAL
- Monocyte-derived alveolar macrophages drive lung fibrosis and persist in the lung over the life span
- (2017) Alexander V. Misharin et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Low-Dose Morphine for Dyspnea in Terminally Ill Patients with Idiopathic Interstitial Pneumonias
- (2017) Yoshinobu Matsuda et al. JOURNAL OF PALLIATIVE MEDICINE
- Health-related quality of life in idiopathic pulmonary fibrosis: Data from the Australian IPF Registry
- (2017) Ian N. Glaspole et al. RESPIROLOGY
- The evidence of benefits of exercise training in interstitial lung disease: a randomised controlled trial
- (2017) Leona M Dowman et al. THORAX
- Unmet needs in the treatment of idiopathic pulmonary fibrosis―insights from patient chart review in five European countries
- (2017) Toby M. Maher et al. BMC Pulmonary Medicine
- Palliative care in interstitial lung disease: living well
- (2017) Michael Kreuter et al. Lancet Respiratory Medicine
- Galectin-3 Is Associated with Restrictive Lung Disease and Interstitial Lung Abnormalities
- (2016) Jennifer E. Ho et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Efficacy of Nintedanib in Idiopathic Pulmonary Fibrosis across Prespecified Subgroups in INPULSIS
- (2016) Ulrich Costabel et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Idiopathic Pulmonary Fibrosis
- (2016) Margaret L. Salisbury et al. CHEST
- The lived experience with idiopathic pulmonary fibrosis: a qualitative study
- (2016) Dorthe Overgaard et al. EUROPEAN RESPIRATORY JOURNAL
- FG-3019 anti-connective tissue growth factor monoclonal antibody: results of an open-label clinical trial in idiopathic pulmonary fibrosis
- (2016) Ganesh Raghu et al. EUROPEAN RESPIRATORY JOURNAL
- Recombinant human pentraxin-2 therapy in patients with idiopathic pulmonary fibrosis: safety, pharmacokinetics and exploratory efficacy
- (2016) Bernt van den Blink et al. EUROPEAN RESPIRATORY JOURNAL
- Continuous Intravenous Morphine Infusion for Severe Dyspnea in Terminally Ill Interstitial Pneumonia Patients
- (2016) Makiko Takeyasu et al. INTERNAL MEDICINE
- Nintedanib in patients with idiopathic pulmonary fibrosis: Combined evidence from the TOMORROW and INPULSIS® trials
- (2016) Luca Richeldi et al. RESPIRATORY MEDICINE
- Safety and efficacy of bridging to lung transplantation with antifibrotic drugs in idiopathic pulmonary fibrosis: a case series
- (2016) Isabelle Delanote et al. BMC Pulmonary Medicine
- Safety and tolerability of acetylcysteine and pirfenidone combination therapy in idiopathic pulmonary fibrosis: a randomised, double-blind, placebo-controlled, phase 2 trial
- (2016) Jürgen Behr et al. Lancet Respiratory Medicine
- Antacid therapy and disease outcomes in idiopathic pulmonary fibrosis: a pooled analysis
- (2016) Michael Kreuter et al. Lancet Respiratory Medicine
- TOLLIP,MUC5B, and the Response toN-Acetylcysteine among Individuals with Idiopathic Pulmonary Fibrosis
- (2015) Justin M. Oldham et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline
- (2015) Ganesh Raghu et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Management of patients with idiopathic pulmonary fibrosis in clinical practice: the INSIGHTS-IPF registry
- (2015) Jürgen Behr et al. EUROPEAN RESPIRATORY JOURNAL
- Palliative care for patients with advanced fibrotic lung disease: a randomised controlled phase II and feasibility trial of a community case conference intervention
- (2015) Sabrina Bajwah et al. THORAX
- Streptococcus pneumoniae triggers progression of pulmonary fibrosis through pneumolysin
- (2015) S. Knippenberg et al. THORAX
- Pirfenidone in Idiopathic Pulmonary Fibrosis: Expert Panel Discussion on the Management of Drug-Related Adverse Events
- (2014) Ulrich Costabel et al. ADVANCES IN THERAPY
- Revealing the Pathogenic and Aging-related Mechanisms of the Enigmatic Idiopathic Pulmonary Fibrosis. An Integral Model
- (2014) Moisés Selman et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- The Role of Bacteria in the Pathogenesis and Progression of Idiopathic Pulmonary Fibrosis
- (2014) Phillip L. Molyneaux et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
- (2014) Talmadge E. King et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
- (2014) Luca Richeldi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Randomized Trial of Acetylcysteine in Idiopathic Pulmonary Fibrosis
- (2014) NEW ENGLAND JOURNAL OF MEDICINE
- An integrated palliative and respiratory care service for patients with advanced disease and refractory breathlessness: a randomised controlled trial
- (2014) Irene J Higginson et al. Lancet Respiratory Medicine
- Lung microbiome and disease progression in idiopathic pulmonary fibrosis: an analysis of the COMET study
- (2014) MeiLan K Han et al. Lancet Respiratory Medicine
- A Multidimensional Index and Staging System for Idiopathic Pulmonary Fibrosis
- (2013) Brett Ley et al. ANNALS OF INTERNAL MEDICINE
- Association Between the MUC5B Promoter Polymorphism and Survival in Patients With Idiopathic Pulmonary Fibrosis
- (2013) Anna L. Peljto et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis
- (2013) Tasha E Fingerlin et al. NATURE GENETICS
- Recombinant human serum amyloid P in healthy volunteers and patients with pulmonary fibrosis
- (2013) M.R. Dillingh et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study
- (2013) Imre Noth et al. Lancet Respiratory Medicine
- Prednisone, Azathioprine, andN-Acetylcysteine for Pulmonary Fibrosis
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- Treating idiopathic pulmonary fibrosis with the addition of co-trimoxazole: a randomised controlled trial
- (2012) Ludmila Shulgina et al. THORAX
- Gastroesophageal Reflux Therapy Is Associated with Longer Survival in Patients with Idiopathic Pulmonary Fibrosis
- (2011) Joyce S. Lee et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Regulation of Transforming Growth Factor-β1–driven Lung Fibrosis by Galectin-3
- (2011) Alison C. MacKinnon et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials
- (2011) Paul W Noble et al. LANCET
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started